Additional file 1: Supplementary Table S1. Univariable and multivariable time-varying Cox model analysis of covariates for progression-free survival in the combination therapy and monotherapy groups
Figure. S5 Pearson correlations between biologically relevant candidate biomarkers. Correlation of ...
Supplemental Materials. Table S1 Consideration of PD-L1 and/or tumor-mutation burden in clinical tri...
Figure S1. Kaplan-Meier curves for overall survival in patients stratified for the occurrence of dru...
Additional file 2: Supplementary figure S1. IrAEs and survival. Kaplan–Meier curves for overall surv...
Additional file 3: Supplementary figure S2. Severe irAEs and efficacy. Kaplan–Meier curves for progr...
Table S1. Baseline characteristics of the unmatched cohorts. Table S2. Multivariable Cox regression ...
Table S1: Multivariate analysis of PFS after controlling for number of prior treatments. Table S2: M...
Figure S1. Trial selection process. Figure S2. Funnel plot comparing hazard ratios for (A) progressi...
Table S3. Multivariate survival analysis (Cox regression model) of effects on survival of (A) tumor-...
S1: baseline characteristics stratified by adverse events. S2-S3: Kaplan-Meier curves for OS and PFS...
Additional file 1: Fig. S1. A selection flowchart for the searched articles. Fig. S2. Forest plots p...
Table S1. Quality assessment: risk of bias by Cochrane Collaborationâs tool. Table S2. Additional ...
Supplemental Methods. Search strategies and number of studies yielded from each database. Table S1. ...
Additional file 1: Table S1. Adverse events leading to dose interruption in either group. Table 2. I...
Table S1. Adverse events (treatment related or not) reported over the entire treatment duration (all...
Figure. S5 Pearson correlations between biologically relevant candidate biomarkers. Correlation of ...
Supplemental Materials. Table S1 Consideration of PD-L1 and/or tumor-mutation burden in clinical tri...
Figure S1. Kaplan-Meier curves for overall survival in patients stratified for the occurrence of dru...
Additional file 2: Supplementary figure S1. IrAEs and survival. Kaplan–Meier curves for overall surv...
Additional file 3: Supplementary figure S2. Severe irAEs and efficacy. Kaplan–Meier curves for progr...
Table S1. Baseline characteristics of the unmatched cohorts. Table S2. Multivariable Cox regression ...
Table S1: Multivariate analysis of PFS after controlling for number of prior treatments. Table S2: M...
Figure S1. Trial selection process. Figure S2. Funnel plot comparing hazard ratios for (A) progressi...
Table S3. Multivariate survival analysis (Cox regression model) of effects on survival of (A) tumor-...
S1: baseline characteristics stratified by adverse events. S2-S3: Kaplan-Meier curves for OS and PFS...
Additional file 1: Fig. S1. A selection flowchart for the searched articles. Fig. S2. Forest plots p...
Table S1. Quality assessment: risk of bias by Cochrane Collaborationâs tool. Table S2. Additional ...
Supplemental Methods. Search strategies and number of studies yielded from each database. Table S1. ...
Additional file 1: Table S1. Adverse events leading to dose interruption in either group. Table 2. I...
Table S1. Adverse events (treatment related or not) reported over the entire treatment duration (all...
Figure. S5 Pearson correlations between biologically relevant candidate biomarkers. Correlation of ...
Supplemental Materials. Table S1 Consideration of PD-L1 and/or tumor-mutation burden in clinical tri...
Figure S1. Kaplan-Meier curves for overall survival in patients stratified for the occurrence of dru...